Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Reinvestment Rate
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Reinvestment Rate of 4.82x as of September 2025, reinvesting CN¥14.73 Million (capex CN¥14.73 Million ) from operating cash flow of CN¥3.05 Million. Check Beijing Hotgen Biotech Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Beijing Hotgen Biotech Co Ltd across 7 annual periods. Explore Beijing Hotgen Biotech Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Beijing Hotgen Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Beijing Hotgen Biotech Co Ltd. For live market cap and broader valuation context, see 688068 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.73x | CN¥1.70 Billion | CN¥978.75 Million | CN¥565.21 Million | ▲ +159.5% |
| 2021 | 0.67x | CN¥1.77 Billion | CN¥2.64 Billion | CN¥398.86 Million | ▼ -92.9% |
| 2020 | 9.35x | CN¥1.54 Billion | CN¥164.62 Million | CN¥172.27 Million | ▼ -87.6% |
| 2019 | 75.11x | CN¥1.45 Billion | CN¥19.37 Million | CN¥88.48 Million | ▲ +193.5% |
| 2018 | 25.59x | CN¥1.41 Billion | CN¥55.04 Million | CN¥42.00 Million | ▲ +330.0% |
| 2017 | 5.95x | CN¥136.61 Million | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.2% |
| 2016 | 0.92x | CN¥41.95 Million | CN¥45.54 Million | CN¥21.18 Million | — |